Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126183152 | 12618315 | 2 | F | 20160801 | 20160804 | 20160803 | 20160808 | EXP | PHJP2016JP022199 | NOVARTIS | 49.00 | YR | Y | 0.00000 | 20160808 | PH | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126183152 | 12618315 | 1 | PS | TEGRETOL | CARBAMAZEPINE | 1 | Oral | 200 MG, UNK | Y | 16608 | 200 | MG | TABLET | ||||||
| 126183152 | 12618315 | 2 | C | RIVOTRIL | CLONAZEPAM | 1 | Unknown | UNK | U | 0 | |||||||||
| 126183152 | 12618315 | 3 | C | BELSOMRA | SUVOREXANT | 1 | Unknown | UNK | U | 0 | |||||||||
| 126183152 | 12618315 | 4 | C | SILECE | FLUNITRAZEPAM | 1 | Unknown | UNK | U | 0 | |||||||||
| 126183152 | 12618315 | 5 | C | ZYPREXA | OLANZAPINE | 1 | Unknown | UNK | U | 0 | |||||||||
| 126183152 | 12618315 | 6 | C | KIPRES | MONTELUKAST SODIUM | 1 | Unknown | UNK | U | 0 | |||||||||
| 126183152 | 12618315 | 7 | C | AMLODIN | AMLODIPINE BESYLATE | 1 | Unknown | UNK | U | 0 | |||||||||
| 126183152 | 12618315 | 8 | C | RABEPRAZOLE | RABEPRAZOLE | 1 | Unknown | UNK | U | 0 | |||||||||
| 126183152 | 12618315 | 9 | C | ARTANE | TRIHEXYPHENIDYL HYDROCHLORIDE | 1 | Unknown | UNK | U | 0 | |||||||||
| 126183152 | 12618315 | 10 | C | GABAPEN | GABAPENTIN | 1 | Unknown | UNK | U | 0 | |||||||||
| 126183152 | 12618315 | 11 | C | GOREISAN /08015901/ | 2 | Unknown | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126183152 | 12618315 | 1 | Schizophrenia |
| 126183152 | 12618315 | 2 | Product used for unknown indication |
| 126183152 | 12618315 | 3 | Product used for unknown indication |
| 126183152 | 12618315 | 4 | Product used for unknown indication |
| 126183152 | 12618315 | 5 | Product used for unknown indication |
| 126183152 | 12618315 | 6 | Product used for unknown indication |
| 126183152 | 12618315 | 7 | Product used for unknown indication |
| 126183152 | 12618315 | 8 | Product used for unknown indication |
| 126183152 | 12618315 | 9 | Product used for unknown indication |
| 126183152 | 12618315 | 10 | Product used for unknown indication |
| 126183152 | 12618315 | 11 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126183152 | 12618315 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126183152 | 12618315 | Drug eruption | |
| 126183152 | 12618315 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126183152 | 12618315 | 1 | 20160730 | 20160801 | 0 |